Quantcast
Last updated on April 18, 2014 at 16:16 EDT

Latest Hologic Stories

2013-06-06 12:29:29

Collaboration features national availability of the APTIMA HPV mRNA-based cervical cancer screening test as well as a focus on developing and expanding access to diagnostic solutions for women's health MADISON, N.J. and BEDFORD, Mass., June 6, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Hologic, Inc. (Hologic) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical...

2013-06-03 16:27:07

QUEBEC CITY, June 3, 2013 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation") today reported financial and operational results for the second quarter ended April 30, 2013. The Corporation announced a net loss of $849,344 or $0.02 per share for this quarter. At the end of the quarter, cash and short-term investments stood at $4,849,305. Second Quarter Highlights On April 2, 2013, the Corporation initiated trading on OTCQX( )International under the symbol...

2013-05-30 12:26:16

Marketing Communications Agency Fuels Growth with Accounts in Real Estate, Medical Device, Healthcare, Financial and Manufacturing CONSHOHOCKEN, Pa., May 30, 2013 /PRNewswire/ -- DDCworks, a leading integrated branding and marketing communications agency, is pleased to announce that it has added several new accounts to its diverse and expanding portfolio of clients and has significantly expanded a number of existing client relationships. These additions are a combined result of the...

2013-05-28 08:28:29

QUEBEC CITY, May 28, 2013 /PRNewswire/ -DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) announced today that it will release its second quarter 2013 results on June 3, 2013, at 4:00 p.m. (EDT). DiagnoCure's management will host a conference call the same day, at 4:30 p.m. (EDT). Interested participants may listen to the call by dialing 1-888-231-8191 or 514-807-9895 and referencing code 77464078 approximately 15 minutes prior to the call. The Corporation will also provide a live webcast of...

2013-05-23 16:26:04

Houston based researchers document the value of 3D mammography as a breast cancer screening technology HOUSTON, May 23, 2013 /PRNewswire/ -- A recently published clinical study conducted at TOPS Comprehensive Breast Center in Houston, Texas, demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls while simultaneously increasing cancer detection. The study, "Implementation of Breast Tomosynthesis in a Routine Screening Practice: An...

2013-05-23 12:27:04

New study builds on significant body of evidence showing improved results using Hologic's 3D mammogram for breast cancer screening BEDFORD, Mass., May 23, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that the first large-scale observational study in a U.S....

2013-05-21 08:29:28

BEDFORD, Mass., May 21, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) approved the use of Hologic's new C-View 2D imaging software. C-View 2D images may now be used in place of the conventional 2D exposure previously required...

2013-05-06 16:27:13

BEDFORD, Mass., May 6, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced its results for the second fiscal quarter ended March 30, 2013. Highlights of the Quarter Include: Financial: Revenues of $612.7 million, net of a $(6.4) million adjustment related to...

2013-05-02 23:24:23

Nationally recognized, breast center continues commitment to 100% early detection of breast cancer with the addition of breast tomosynthesis. Montclair, NJ (PRWEB) May 02, 2013 Montclair Breast Center is one of the first women´s centers in New Jersey to offer 3D mammography (breast tomosynthesis) for breast cancer screening. Breast tomosynthesis produces a three-dimensional view of the breast tissue that helps radiologists identify and characterize individual breast structures without...

2013-05-01 16:31:16

Addition of tomosynthesis increased breast cancer detection and simultaneously reduced recall rates BEDFORD, Mass., May 1, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women, today announced the publication of the final results of a large-scale prospective study comparing breast...